EVIPLERA 200 mg/1 tableta+ 25 mg/1 tableta+ 245 mg/1 tableta film tableta Bosnien und Herzegowina - Kroatisch - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

eviplera 200 mg/1 tableta+ 25 mg/1 tableta+ 245 mg/1 tableta film tableta

medicopharmacia d.o.o. - emtricitabin, emtricitabin, Тенофовир disoproksil, rilpivirin, Тенофовир disoproksil - film tableta - 200 mg/1 tableta+ 25 mg/1 tableta+ 245 mg/1 tableta - 1 film tableta sadrži: 200 mg emtricitabin, 25 mg rilpivirin (u obliku rilpivirin hidrohlorida) i 245 mg tenofovir disoproksil (u obliku tenofovir disoproksil fumarata)

Calquence Europäische Union - Kroatisch - EMA (European Medicines Agency)

calquence

astrazeneca ab - acalabrutinib - leukemija, limfocitna, kronična, b-stanica - antineoplastic agents, protein kinase inhibitors, - calquence as monotherapy or in combination with obinutuzumab is indicated for the treatment of adult patients with previously untreated chronic lymphocytic leukaemia (cll). calquence as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukaemia (cll) who have received at least one prior therapy.